Vericiguat Achieves High Target-Dose Rates in Indian Worsening Heart Failure Study
A 48-week phase IV study of 205 Indian patients with worsening heart failure and reduced ejection fraction found that 91.6% ...
Tag: soluble guanylate cyclase stimulator
POPULAR NEWS
-
Systematic review maps end-of-life psychosocial and spiritual needs in physical disability
-
Text Message Campaign Reached Only a Third of Patients Overdue for Colorectal Cancer Screening
-
FOXO1 Emerges as Candidate Regulator and Biomarker in Hip Dysplasia
-
Regulators, developers and clinicians in Shenzhen voice concerns over medical AI governance